Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Intec Pharma Ltd buy stratec

Start price
?3.70
16.08.18 / 50%
Target price
€9.92
31.07.19
Performance (%)
-89.33%
End price
€0.39
31.07.19
Summary
This prediction ended on 31.07.19 with a price of €0.39. The BUY prediction by stratec for Intec Pharma Ltd performed very badly with a performance of -89.33%. stratec has 50% into this prediction
Performance without dividends (%)
Name 1w 1m 1y 3y
Intec Pharma Ltd - - - -
iShares Core DAX® 1.280% 1.027% 11.234% 16.273%
iShares Nasdaq 100 -2.457% -4.650% 23.181% 39.418%
iShares Nikkei 225® -2.006% -2.091% 6.745% 6.545%
iShares S&P 500 -0.662% -1.246% 22.521% 40.218%

Comments by stratec for this prediction

In the thread Intec Pharma Ltd diskutieren
Prediction Buy
Perf. (%) -89.33%
Target price 9.922
Change
Ends at 31.07.19

stratec stimmt der Buy-Einschätzung von tamam zu

stratec stimmt am 16.08.2018 der Buy-Einschätzung von tamam mit dem Kursziel 5,2$ zu.
Überschrift: Intec , a good time to go ¨bottom-fishing¨


Intec reported 2Q18 with a net loss of $11M and ended the quarter with $66.2M in cash on the balance sheet, sufficient runway at the current burn rate into 2H19 and through the pivotal P3 data for Accordion Pill (NYSE:AP)) in Parkinson’s Disease.



Prediction Buy
Perf. (%) -89.33%
Target price 9.922
Change
Ends at 31.07.19

(Vom Mitglied beendet)